MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.

Furthermore, the combination treatment of anti-PD-L1 and 4-IPP, although it showed a trend toward improved antitumor response on TMT cells, did not significantly improve outcome compared with antibody alone ( Figure 2d ).

also in 53,322 other papers